E-LIB Suche - Ergebnisse für: Arya, Mark

1

Immunogenicity and safety of a bivalent (omicron BA.5 plus ..:

Bennett, Chijioke ; Woo, Wayne ; Bloch, Mark...
The Lancet Infectious Diseases. 24 (2024) 6 - p. 581-593 , 2024

2

Strong CD4+ T-Cell Responses to Ancestral and Variant Spike..:

Fries, Louis ; Formica, Neil ; Mallory, Raburn M...
The Journal of Infectious Diseases. 228 (2023) 6 - p. 734-741 , 2023

Link: https://doi.org/10.1093/..

3

Immunogenicity and Safety of Heterologous Omicron BA.1 and ..:

Bennett, Chijioke ; Rivers, E Joy ; Woo, Wayne...
The Journal of Infectious Diseases. , 2023

Link: https://doi.org/10.1093/..

4

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadm..:

Athan, Eugene ; Baber, James ; Quan, Karen...
Clinical Infectious Diseases. 78 (2023) 5 - p. 1360-1368 , 2023

Link: https://doi.org/10.1093/..

5

Tolerability and Efficacy of a 10:25 Preparation of Δ9-Tetr..:

Glare, Paul ; Chye, Richard ; Bloch, Mark...
Medical Cannabis and Cannabinoids. 6 (2023) 1 - p. 66-76 , 2023

Link: https://doi.org/10.1159/..

6

Safety and Immunogenicity of the BNT162b2 Vaccine Coadminis..:

Murdoch, Louise ; Quan, Karen ; Baber, James A....
Infectious Diseases and Therapy. 12 (2023) 9 - p. 2241-2258 , 2023

Link: https://doi.org/10.1007/..

7

Efficacy and safety of topical brepocitinib for the treatme..:

Landis, Megan N. ; Arya, Mark ; Smith, Stacy...
British Journal of Dermatology. 187 (2022) 6 - p. 878-887 , 2022

Link: https://doi.org/10.1111/..

8

A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusio..:

Baber, James ; Arya, Mark ; Moodley, Yuben...
The Journal of Infectious Diseases. 226 (2022) 12 - p. 2054-2063 , 2022

Link: https://doi.org/10.1093/..

9

Efficacy and safety of methionine aminopeptidase 2 inhibiti..:

Proietto, Joseph ; Malloy, Jaret ; Zhuang, Dongliang...
Diabetologia. 61 (2018) 9 - p. 1918-1922 , 2018

Link: https://doi.org/10.1007/..

10

Safety of the adjuvanted recombinant zoster vaccine in adul..:

Ocran-Appiah, Josephine ; Boutry, Céline ; Hervé, Caroline...
Vaccine. 39 (2021) 1 - p. 6-10 , 2021

Link: https://doi.org/10.1016/..

11

Tolerability and Efficacy of a 10:25 Preparation of Δ9-Tetr..:

Glare, Paul ; Chye, Richard ; Bloch, Mark...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350899/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Efficacy and safety of topical brepocitinib for the treatme..:

Landis, Megan N ; Arya, Mark ; Smith, Stacy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092158/. , 2022

Link: http://www.ncbi.nlm.nih...

13

A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusio..:

Baber, James ; Arya, Mark ; Moodley, Yuben...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749002/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Safety and immunogenicity following a homologous booster do..:

Mallory, Raburn M ; Formica, Neil ; Pfeiffer, Susan...
The Lancet Infectious Diseases. , 2022

Link: http://hdl.handle.net/10..

15

Tolerability and Efficacy of a 10:25 Preparation of Δ9-Tetr..:

Paul Glare ; Richard Chye ; Mark Bloch...
https://beta.karger.com/Article/FullText/531232. , 2023

Link: https://doi.org/10.1159/..